Intensive Recovery
Natural health product licensed in Canada
- Other names
- Alumier MD Intensive Recovery, Alumier MD Intensive Recovery Anti-Itch Cream, Intensive Recovery Anti-Itch Cream
- Licence holder
- Alumier Europe Ltd.
- NPN or DIN-HM
- 80065215
- Status
- Active licence
- Licence date
- 16 November 2015
- Revision date
- 14 April 2026
- Form
- Crème
- Route of administration
- Topique
- Application type
- Officinale
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| (11bêta)-11,17,21-trihydroxy-prégn-4-ène-3,20-dione Source : Hydrocortisone | 1 % |
Non-medicinal ingredients
Lécithine, Extrait de feuilles d'Eucalyptus globulus, tricaprylin, Extrait de Fleur/Feuilles/Tige de Lavandula Angustifolia (Lavande), Extrait de feuilles de Rosmarinus Officinalis (Romarin), Extrait de fleur Anthemis nobilis, Extrait de sclérotium de Poria cocos, Extrait de fruit de Pyrus malus (pomme), Extrait de gomme de Boswellia serrata, Gomme de xanthane, Extrait de menthe verte, Cuivre tripeptide-1, Caprylyl Glycol, Céramide NP, Beurre de Butyrospermum parkii (Karité), Extrait de Camellia sinensis, Chlorure d'hydroxyéthyl behenamidopropyl dimonium, Niacinamide, Hydroxyde de sodium, Triglycéride caprylique/caprique, xylitol, Céramide NG, Lécithine hydrogénée, Squalane, Insaponifiables d'huile d'olive hydrogénée, Resvératrol, Extrait de rose, Extrait de fouet de mer, Extrait de Aspalathus linearis, Tétrapeptide-14, Pentylène glycol, Diméthicone, Extrait de fruit de Vaccinium Macrocarpon (canneberge), Glycérine, Anhydroxylitol, Propanediol, Behenyl alcohol, Sesquicaprylate de xylityle, Hinokitiol, Méthyl Stéaroyl taurate de sodium, Copolymère d'acrylates sodiques, acide caprylique, Méthacrylate de poly (méthyle), Eau, Jus de feuilles d'Aloe Barbadensis, EDTA de sodium, Beurre de graines de Theobroma cacao (Cacao), Ethylhexylglycérine, Extrait de feuilles de Pogostemon cablin, Huile de graine de Simmondia Chinensis (Jojoba), Extrait de feuilles d'Aspalathus Linearis, Extrait de miel
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adolescents | minimum: 12 years ; maximum: 17 years | 1 Crème | minimum: 1 Tous les jours ; maximum: 4 Tous les jours |
| Enfants | minimum: 2 years ; maximum: 11 years | 1 Crème | minimum: 1 Tous les jours ; maximum: 4 Tous les jours |
| Adultes | minimum: 18 years | 1 Crème | minimum: 1 Tous les jours ; maximum: 4 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
For temporary relief of minor skin irritations associated with redness, itching, dryness and scaling. For temporary relief of minor skin irritations, rashes, itching and redness (due to eczema, insect bites, poison ivy, poison oak, poison sumac, seborrheic dermatitis, psoriasis, or contact dermatitis) (e.g. caused by soaps, detergents, cosmetics and/or jewellery)), seborrheic dermatitis, psoriasis. Anti-pruritic.Anti-itch.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80065215
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.